I love to talk about real estate to my friends and family. But each time, in the middle of the conversation, the same words come up: “risky”, “complex”, “uncertain”, “time consuming”… What if all this were about to change thanks to technology? Here are three areas where digital is dusting off real estate. Online Tools and Mortgage Simulators Online simulators are a down-to-earth living example … Continue reading When technology dusts off real estate
According to several analysts, Google commits suicide. The software giant takes too much risk and is unable to control its businness. Why is it so and what is Google's last wish?Read More >> Continue reading Does google take too much risk?
Apple Inc (NASDAQ:AAPL) seeking to secure its mobile supply chain, has opened discussions to buy control of a Japanese venture that makes key microchips for its iPhone screens, sources familiar with the matter say. Apple Inc. (NASDAQ:AAPL) stock performance was 0.17% in last session and finished the day at $542.55. Traded volume was 6.44million shares in the last session and the average volume of the … Continue reading Consumer Goods Active Runners: Apple Inc. (NASDAQ:AAPL), General Motors (NYSE:GM), Tesla Motors Inc (NASDAQ:TSLA), The Coca-Cola Company (NYSE:KO)
Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) major shareholder Sabby Management, Llc acquired 16,203 shares of Celsus Therapeutics PLC stock in a transaction dated Thursday, March 27th. The shares were purchased at an average price of $6.66 per share, for a total transaction of $107,911.98. Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) stock performance was -5.24% in last session and finished the day at $6.15. Traded volume was 35.9K … Continue reading Biotech Bearish Stocks: Celsus Therapeutics (NASDAQ:CLTX), Reliv International (NASDAQ:RELV), Fate Therapeutics Inc (NASDAQ:FATE), CorMedix Inc. (NYSEMKT:CRMD)
Ocera Therapeutics Inc (NASDAQ:OCRX) is a company with one main value driver, OCR002. Financially, the company is now sitting on $47.2 M and will be spending $30M in the 2014 financial year. It has about one year in cash. Last year, it spent $3.5M in R&D and these costs are set to increase as it ramps up the Phase 2 trials for OCR002. Ocera Therapeutics … Continue reading Biotech Decliners: Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech, Inc. (OTCMKTS:MRNA), CorMedix Inc. (NYSEMKT:CRMD), Idera Pharmaceuticals Inc (NASDAQ:IDRA)
Companhia Energetica Minas Gerais (ADR) (NYSE:CIG) had its stock coverage assumed at Goldman Sachs Group Inc (NYSE:GS). The firm assigned buy rating on the stock. That positive rating of the stock came hot on the heels of the upgrade from Zacks, where analysts at Zacks assigned neutral on the stock from underperform. Companhia Energetica Minas Gerais (ADR) (NYSE:CIG) stock performance was 0.89% in last session … Continue reading Utilities Active Runners: Companhia Energetica Minas Gerais (ADR) (NYSE:CIG), AES Corp (NYSE:AES), Exelon Corporation (NYSE:EXC), PG&E Corporation (NYSE:PCG)
